Skip to main content

Neuro-Ophthalmologic Evaluation of Pituitary Tumors

  • Chapter
Diagnosis and Management of Pituitary Tumors

Abstract

The intricate anatomy of the fiber pathways within the optic chiasm, nerves, and tracts manifests itself in a myriad of visual symptoms. Sir Isaac Newton (cited by Rucker) (1) first speculated about the crossing of the fiber tracts within the chiasm in 1704. Since then, through the landmark writings of Harvey Cushing (2) and Traquair (3), and to the present time, the effects of pituitary and related tumors on the visual pathway have intrigued neuro-surgeons, ophthalmologists, and neurologists. Several excellent reviews of the neuro-ophthalmologic features of the optic chiasm and pituitary tumors have been published (4–12). This chapter reviews new developments in the embryology of the optic chiasm, the nature and pathogenesis of visual symptoms in relation to relevant anatomy of the chiasm and optic nerves, visual syndromes caused by pituitary and related tumors, and the recovery of visual dysfunction following various management strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rucker CW. The concept of a semidecussation of the optic nerves. Arch Ophthalmol 1958;59:159–171.

    CAS  Google Scholar 

  2. Cushing H. The chiasmal syndrome of primary optic atrophy and bitemporal field defects in adults with a normal sella turcica. Arch Ophthalmol 1930;3:704–735.

    Google Scholar 

  3. Scott GI. Traquair’s Clinical Perimetry, 7th ed. Henry Kimpton, London, England, 1957, pp. 218–252.

    Google Scholar 

  4. Arnold AC. Neuroophthalmologic evaluation of pituitary disorders. In: Melmed S, ed. The Pituitary. Blackwell Scientific, Cambridge, MA, 1995, pp. 687–707.

    Google Scholar 

  5. Hoyt WF. Correlative functional anatomy of the optic chiasm. Clin Neurosurg 1970;17:189–208.

    PubMed  CAS  Google Scholar 

  6. Melen O. Neuro-ophthalmologic features of pituitary tumors. Endocrinol Metab Clin 1987;16:585–608.

    CAS  Google Scholar 

  7. Slamovits TL. Anatomy and Physiology of the Optic Chiasm. In: Miller NR, Newman NJ, eds. Walsh and Hoyt’s Clinical Neuro-Ophthalmology. vol. 1, 5th ed. Williams & Wilkins, Baltimore, 1998, pp. 85–100.

    Google Scholar 

  8. Gittinger JW, Jr. Tumors of the Pituitary Gland. In: Miller NR, Newman NJ, eds. Walsh and Hoyt’s Clinical Neuro-Ophthalmology. vol. 2, 5th ed. Williams & Wilkins, Baltimore, 1998, pp. 2141–2221.

    Google Scholar 

  9. Wormington CM. Pituitary adenoma: diagnosis and management. J Am Optom Assoc 1989;60:929–935.

    PubMed  CAS  Google Scholar 

  10. Lesser RL. Neuro-ophthalmic aspects of pituitary disease. In: Goodrich I, Lee KJ, eds. The Pituitary. Clinical Aspects of Normal and Abnormal Function. Elsevier Science, Amsterdam, The Netherlands, 1987, pp. 67–85.

    Google Scholar 

  11. Alleyne Jr CH, Newman N. Neuro-Ophthalmology of Pituitary Tumors. In: Krisht AF, Tindall GT, eds. Pituitary Disorders. Lippincott Williams & Wilkins, Baltimore, 1999, pp. 165–185.

    Google Scholar 

  12. Chung SM. Neuro-ophthalmic manifestations of pituitary tumors. Neurosurg Clin N Am 1999;10:717–729.

    PubMed  CAS  Google Scholar 

  13. Barber AN, Ronstrom GN, Muelling Jr RJ. Development of the visual pathway: optic chiasm. Arch Ophthalmol 1954;52:447–453.

    CAS  Google Scholar 

  14. Horton JC, Greenwood MM, Hubel DH. Non-retinotopic arrangement of fibres in the cat optic nerve. Nature 1979;282:720–722.

    PubMed  CAS  Google Scholar 

  15. Guillery RW, Mason CA, Taylor JSH. Developmental determinants at the mammalian optic chiasm. J Neurosci 1995;15:4727–4737.

    PubMed  CAS  Google Scholar 

  16. Sretavan DW, Pure E, Siegel MW, Reichardt LF. Disruption of retinal axon ingrowth by ablation of embryonic mouse optic chiasm neurons. Science 1995;269:98–101.

    PubMed  CAS  Google Scholar 

  17. Marcus RC, Shimamura K, Sretavan D, Lai E, Rubenstein JLR, Mason CA. Domains of regulatory gene expression and the developing optic chiasm: correspondence with retinal axon paths and candidate signaling cells. J Comp Neurol 1999;403:346–358.

    PubMed  CAS  Google Scholar 

  18. Mason CA, Sretavan DW. Glia, neurons, and axon pathfinding during optic chiasm development. Curr Opin Neurobiol 1997;7: 647–653.

    PubMed  CAS  Google Scholar 

  19. Sretavan DW, Feng L, Pure E, Reichardt LF. Embryonic neurons of the developing optic chiasm express L 1 and CD44, cell surface molecules with opposing effects on retinal axon growth. Neuron 1994;12:957–975.

    PubMed  CAS  Google Scholar 

  20. Sakamoto H. Development of the trigeminus, with particular reference to the ophthalmic nerve. Acta Soc Ophthal Jap 1952;56: 1355–1357.

    Google Scholar 

  21. Sakamoto H. Embryology of the third, fourth, and sixth cranial nerves. Acta Soc Ophthal Jap 1953;57:146–148.

    Google Scholar 

  22. Marcus RC, Blazeski R, Godement P, Mason Ca. Retinal axon divergence in the optic chiasm: Uncrossed axons diverge from crossed axons within a midline glial specialization. J Neurosci 1995;15:3716–3729.

    PubMed  CAS  Google Scholar 

  23. Sretavan DW, Reichardt LF. Time-lapse video analysis of retinal ganglion cell axon pathfinding at the mammalian optic chiasm: Growth cone guidance using intrinsic chiasm cues. Neuron 1993; 10:761–777.

    PubMed  CAS  Google Scholar 

  24. Godement P, Mason CA. Retinal axon divergence in the optic chiasm: Dynamics of growth cone behavior at the midline. J Neurosci 1994;14:7024–7039.

    PubMed  CAS  Google Scholar 

  25. Chan SO, Wong KF, Chung KY, Yung WH. Changes in morphology and behavior of retinal growth cones before and after crossing the midline of the mouse chiasm—a confocal microscopy study. Eur J Neurosci 1998;10:2511–2522.

    PubMed  CAS  Google Scholar 

  26. Godement P, Vanselow J, Thanos S, Bonhoeffer F. A study of the developing visual systems with a new method of staining neurons and their processes in fixed tissue. Development 1987;101: 697–713.

    PubMed  CAS  Google Scholar 

  27. Taylor JSH, Guillery RW. The effect of a very early monocular enucleation upon the development of the uncrossed retinofugal pathway in ferrets. J Comp Neurol 1995;357:331–340.

    PubMed  CAS  Google Scholar 

  28. Chan SO, Chung KY, Taylor JSH. The effects of early prenatal monocular enucleation on the routing of uncrossed retinofugal axons and the cellular environment at the chiasm of mouse embryos. Eur J Neurosci 1999;11:3225–3235.

    PubMed  CAS  Google Scholar 

  29. Stretavan DW, Kruger K. Randomized retinal ganglion cell axon routing at the optic chiasm of GAP-43-deficient mice: association with midline recrossing and lack of normal ipsilateral axon turning. J Neurosci 1998;18:10502–10513.

    Google Scholar 

  30. Kaplan SL, Grumbach MM, Aubert ML. The orthogenesis of pituitary hormones and hypothalamic factors in the human fetus: Maturation of central nervous system regulation of anterior pituitary functions. Recent Prog Horm Res 1976;32:161–243.

    PubMed  CAS  Google Scholar 

  31. Sabshin JK. The pituitary gland—anatomy and embryology. In: Goodrich I, Lee KJ, eds. The Pituitary. Clinical Aspects of Normal and Abnormal Function. Elsevier Science, Amsterdam, The Netherlands, 1987, pp. 19–27.

    Google Scholar 

  32. Robinson F, Goodrich I. Neurological manifestations of extrasellar expanding pituitary adenomas. In: Goodrich I, Lee KJ, eds. The Pituitary. Clinical Aspects of Normal and Abnormal Function. Elsevier Science, Amsterdam, The Netherlands, 1987, pp. 55–65.

    Google Scholar 

  33. Hudson H, Rissell C, Gauderman WJ, Feldon SE. Pituitary tumor volume as a predictor of postoperative visual field recovery. J Clin Neuroophthalmol 1991;11:280–283.

    PubMed  CAS  Google Scholar 

  34. Bergland RM, Ray BS, Torack RM. Anatomical variations in the pituitary gland and adjacent structures in 255 human autopsy cases. J Neurosurg 1968;28:93–99.

    PubMed  CAS  Google Scholar 

  35. Ikeda H, Yoshimoto T. Visual disturbances in patients with pituitary adenoma. Acta Neurol Scand 1995;92:157–160.

    PubMed  CAS  Google Scholar 

  36. Unsold R, Hoyt WF. Band atrophy of the optic nerve: the histology of temporal hemianopsia. Arch Ophthalmol 1980;98:1637–1638.

    PubMed  CAS  Google Scholar 

  37. Naito J. Retrogeniculate projection fibers in the monkey optic chiasm: a demonstration of the fiber arrangement by means of wheat germ agglutinin conjugated to horseradish peroxidase. J Comp Neurol 1994;346:559–571.

    PubMed  CAS  Google Scholar 

  38. Kupfer C, Chumbley L, Downer JC. Quantitative histology of optic nerve, optic tract and lateral geniculate nucleus of man. J Anat 1967;101:393–401.

    PubMed  CAS  Google Scholar 

  39. Brouwer B, Zeeman WPC. Experimental anatomical investigations concerning the projection of the retina of the primary optic centers in apes. J Neurol Psychopathol 1925;6:1–10.

    PubMed  CAS  Google Scholar 

  40. Brouwer B, Zeeman WPC. The projection of the retina in the primary optic neuron in monkeys. Brain 1926;49:1–35.

    Google Scholar 

  41. Hoyt WF, Lois O. The primate chiasm: Details of visual fiber organization studied by silver impregnation techniques. Arch Ophthalmol 1963;70:69–85.

    PubMed  CAS  Google Scholar 

  42. Hoyt WF, Tudor RC. The course of the parapapillary temporal retinal axons through the anterior optic nerve: A Nauta degeneration study in the primate. Arch Ophthalmol 1963;69:503–507.

    PubMed  CAS  Google Scholar 

  43. Hoyt WF, Lois O. Visual fiber anatomy in the infrageniculate pathway of the primate. uncrossed and crossed retinal fiber projection studied by Nauta silver stain. Arch Ophthalmol 1962;68: 94–106.

    PubMed  CAS  Google Scholar 

  44. Glaser JS. Neuro-ophthalmology, 2nd ed. J.B. Lippincott, Philadelphia, 1990, p. 71.

    Google Scholar 

  45. Reese BE. Clinical implications of the fibre order in the optic pathway of primates. Neurol Res 1993;15:83–86.

    PubMed  CAS  Google Scholar 

  46. Kosmorsky GS, Tomsak RL, Diskin DK. Absence of the relative afferent pupillary defect with monocular temporal visual field loss. J Clin Neuroophthalmol 1992;12:181–191.

    PubMed  CAS  Google Scholar 

  47. Horton JC. Wilbrand’s knee of the primate optic chiasm is an artefact of monocular enucleation. Trans Am Ophthalmol Soc 1997;95: 579–609.

    PubMed  CAS  Google Scholar 

  48. Bergland R, Ray BR. The arterial supply of the human optic chiasm. J Neurosurg 1969;31:327–334.

    PubMed  CAS  Google Scholar 

  49. Dawson BH. The blood vessels of the human optic chiasma and their relation to those of the hypophysis and hypothalamus. Brain 1958;81:207–217.

    PubMed  CAS  Google Scholar 

  50. Miller NR. Vascular supply of the visual pathways. In: Miller NR, ed. Walsh and Hoyt’s Clinical Neuro-ophthalmology. vol. 1, 4th ed. 1982, pp. 104–107.

    Google Scholar 

  51. Perlmutter D, Rhoton AL. Microsurgical anatomy of the anterior cerebral-anterior communicating recurrent artery complex. J Neurosurg 1976;45:259–272.

    PubMed  CAS  Google Scholar 

  52. Wollschlaeger P, Wollschlaeger G, Ide C, Hart W. Arterial blood supply of the human optic chiasm and surrounding structures. Ann Ophthalmol 1971;3:862–869.

    PubMed  CAS  Google Scholar 

  53. Francois J, Neetens A, Collette JM. Vascularization of the primary optic pathways. Br J Ophthalmol 1958;42:65–80.

    PubMed  CAS  Google Scholar 

  54. O’Connell JEA. The anatomy of the optic chiasma and heteronymous hemianopia. J Neurol Neurosurg Psychiatry 1973;36:710–723.

    PubMed  Google Scholar 

  55. Hedges TR. The preservation of the upper nasal field in the chiasmal syndrome: An anatomic explanation. Trans Am Ophthalmol Soc 1969;67:131–141.

    PubMed  CAS  Google Scholar 

  56. McDonald WI. The symptomatology of tumours of the anterior visual pathways. Can J Neurol Sci 1982;9:381–390.

    PubMed  CAS  Google Scholar 

  57. Lao Y, Gao H, Zhong Y. Vascular architecture of the human optic chiasma and bitemporal hemianopia. Chin Med Sci J 1994;9:38–44.

    PubMed  CAS  Google Scholar 

  58. Halle AA, Drewry RD, Robertson JT. Ocular manifestations of pituitary adenomas. South Med J 1983;76:732–735.

    PubMed  CAS  Google Scholar 

  59. Clifford-Jones RE, McDonald WI, Landon DN. Chronic optic nerve compression: An experimental study. Brain 1985;108:241–262.

    PubMed  Google Scholar 

  60. Jacobson SG, Eames RA, McDonald WI. Optic nerve fibre lesions in adult cats: Pattern of recovery of spatial vision. Exp Brain Res 1979;36:491–508.

    PubMed  CAS  Google Scholar 

  61. Tassinari G, Marzi CA, Lee BB, Di Lollo V, Campara D. A possible selective impairment of magnocellular function in compression of the anterior visual pathways. Exp Brain Res 1999;127:391–401.

    PubMed  CAS  Google Scholar 

  62. Tassinari G, Campara D, Balercia G, Chilosi M, Martignoni G, Marzi CA. Magno- and parvocellular pathways are segregated in the human optic tract. Neuroreport 1994;5:1425–1428.

    PubMed  CAS  Google Scholar 

  63. Porciatti V, Ciavarella P, Ghiggi MR, D’Angelo V, Padovano S, Grifa M, Moretti G. Losses of hemifield contrast sensitivity in patients with pituitary adenoma and normal visual acuity and visual field. Clin Neurophysiol 1999;110:876–886.

    PubMed  CAS  Google Scholar 

  64. Gutowski NJ, Heron JH, Scase MO. Early impairment of foveal magno- and parvocellular pathways in juxta chiasmal tumours. Vision Res 1997;37:1401–1408.

    PubMed  CAS  Google Scholar 

  65. Garfield J, Neil-Dwyer G. Delay in diagnosis of optic nerve and chiasmal compression presenting with unilateral failing vision. Br Med J 1975;1:22–25.

    PubMed  CAS  Google Scholar 

  66. Segal AJ, Fishman RS. Delayed diagnosis of pituitary tumors. Am J Ophthalmol 1975;79:77–81.

    PubMed  CAS  Google Scholar 

  67. Mohr G, Hardy J, Comtois R, Beauregard H. Surgical management of giant pituitary adenomas. Can J Neurol Sci 1990;17:62–66.

    PubMed  CAS  Google Scholar 

  68. Gott PS, Weiss MH, Apuzzo M, Van Der Meulen JP. Checkerboard visual evoked response in evaluation and management of pituitary tumors. Neurosurgery 1979;5:553–558.

    PubMed  CAS  Google Scholar 

  69. Brecelj J. A VEP study of the visual pathway function in compressive lesions of the optic chiasm. Full-field versus half-field stimulation. Electroencephalogr Clin Neurophysiol 1992;84:209–218.

    PubMed  CAS  Google Scholar 

  70. Harrington DO. The Visual Fields. A Textbook and Atlas of Clinical Perimetry, 3rd ed. C.V. Mosby Co., Saint Louis, 1971, pp.14–47.

    Google Scholar 

  71. Harrington DO. The Visual Fields. A Textbook and Atlas of Clinical Perimetry, 3rd ed. C.V. Mosby, Saint Louis, 1971, pp. 48–69.

    Google Scholar 

  72. Sharpe JA. Visual dysfunction with basal skull tumours. Can J Neurol Sci 1985;12:332–335.

    PubMed  CAS  Google Scholar 

  73. Knight CL, Hoyt WF, Wilson CB. Syndrome of incipient prechiasmal optic nerve compression. Arch Ophthalmol 1972;87:1–11.

    Google Scholar 

  74. Trautmann JC, Laws E, Jr. Visual status after transsphenoidal surgery at the Mayo Clinic, 1971–1982. Am J Ophthalmol 1983;96: 200–208.

    PubMed  CAS  Google Scholar 

  75. Cohen AR, Cooper PR, Kupersmith MJ, Flamm ES, Ransohoff J. Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery 1985;17:446–452.

    PubMed  CAS  Google Scholar 

  76. Anderson D, Faber P, Marcovitz S, Hardy J, Lorenzetti D. Pituitary tumors and the ophthalmologist. Ophthalmology 1983;90:1265–1270.

    PubMed  CAS  Google Scholar 

  77. Wilson CB, Dempsey LC. Transsphenoidal microsurgical removal of 250 pituitary adenomas. J Neurosurgery 1978;48:13–22.

    CAS  Google Scholar 

  78. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J. The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 1991;68: 860–866.

    PubMed  CAS  Google Scholar 

  79. Trobe JD, Tao AH, Schuster JJ. Perichiasmal tumors: Diagnostic and prognostic features. Neurosurgery 1984;15:391–399.

    PubMed  CAS  Google Scholar 

  80. Symon L, Jakubowski J. Transcranial management of pituitary tumours with suprasellar extension. J Neurol Neurosurg Psychiatry 1979;42:123–133.

    PubMed  CAS  Google Scholar 

  81. Wray SH. Neuro-ophthalmologic manifestations of pituitary and parasellar lesions. Clin Neurosurg 1976;24:86–117.

    Google Scholar 

  82. Hollenhorst RW, Younge BR. Ocular manifestations produced by adenomas of the pituitary gland: analysis of 1000 cases. In: Kohler PO, Ross GT, eds. Diagnosis and Treatment of Pituitary Tumours. Excerpta Medica, Amsterdam, 1973, pp. 53–64.

    Google Scholar 

  83. Elkington SG. Pituitary adenoma: pre-operative symptomatology in a series of 260 patients. Br J Ophthalmol 1968;52:322–328.

    PubMed  CAS  Google Scholar 

  84. Sullivan LJ, O’Day J, McNeill P. Visual outcomes of pituitary adenoma surgery. St. Vincent’s Hospital 1968–1987. J Clin Neuroophthalmol 1991;11:262–267.

    PubMed  CAS  Google Scholar 

  85. Harrington DO. The Visual Fields. A Textbook and Atlas of Clinical Perimetry, 3rd ed. C.V. Mosby Co, Saint Louis, 1971, pp. 251–298.

    Google Scholar 

  86. Blaauw G, Braakman R, Çuhadar M, Hoeve LJ, Lamberts SWJ, Poublon RML, Singh R, Wijngaarde R. Influence of transsphenoidal hypophysectomy on visual deficit due to a pituitary tumour. Acta Neurochir (Wien) 1986;83:79–82.

    CAS  Google Scholar 

  87. Findlay G, McFadzean RM, Teasdale G. Recovery of vision following treatment of pituitary tumours: Application of a new system of visual assessment. Trans Ophthalmol Soc UK 1983;103 (pt 2):212–216.

    PubMed  Google Scholar 

  88. Younge BR. Midline tilting between seeing and nonseeing areas in hemianopia. Mayo Clin Proc 1976;51:562–568.

    PubMed  CAS  Google Scholar 

  89. Sugita K, Sato O, Hirota T, Tsugane R, Kageyama N. Scotomatous defects in the central visual field in pituitary adenomas. Neurochirurgia 1975;18:155–162.

    PubMed  CAS  Google Scholar 

  90. Bird A. Field loss due to lesions at the anterior angle of the chiasm. Proc Royal Soc Med 1972;65:519–520.

    CAS  Google Scholar 

  91. Karanjia N, Jacobson DM. Compression of the prechiasmatic optic nerve produces a junctional scotoma. Am J Ophthalmol 1999;128: 256–258.

    PubMed  CAS  Google Scholar 

  92. Hershenfeld SA, Sharpe JA. Monocular temporal hemianopia. Br J Ophthalmol 1993;77:424–427.

    PubMed  CAS  Google Scholar 

  93. Mojon DS, Odel JG, Rios RJ, Hirano M. Pituitary adenoma revealed by paracentral junctional scotoma of Traquair. Ophthalmologica 1997;211:104–108.

    PubMed  CAS  Google Scholar 

  94. Thompson HS, Montague P, Cox TA, Corbett JJ. The relationship between visual acuity, pupillary defect, and visual field loss. Am J Ophthalmol 1982;93:681–688.

    PubMed  CAS  Google Scholar 

  95. Charteris DG, Cullen JF. Binasal field defects in primary empty sella syndrome. J Neuroophthalmol 1996;16:110–114.

    PubMed  CAS  Google Scholar 

  96. Parravano JG, Toledo A, Kucharczyk W. Dimensions of the optic nerves, chiasm, and tracts: MR Quantitative comparison between patients with optic atrophy and normals. J Comput Assist Tomogr 1993;17:688–690.

    PubMed  CAS  Google Scholar 

  97. Newman NM. Ophthalmoscopic observation of the retinal nerve fiber layer. Trans Am Acad Ophthalmol Otolaryngol 1977;83: 786–796.

    CAS  Google Scholar 

  98. Newman NM, Tornambe PE, Corbett JJ. Ophthalmoscopy of the retinal nerve fiber layer. Use in detection of neurologic disease. Arch Neurol 1982;39:226–233.

    PubMed  CAS  Google Scholar 

  99. Lundstrom M, Frisen L. Atrophy of optic nerve fibers in compression of the chiasm-degree and distribution of ophthalmoscopic changes. Acta Ophthalmol 1976;54:623–640.

    CAS  Google Scholar 

  100. Kubie LS, Beckmann JW. Diplopia without extra-ocular palsies, caused by heteronymous defects in the visual fields associated with defective macular vision. Brain 1929;52:317–333.

    Google Scholar 

  101. Borchert MS, Lessell S, Hoyt WF. Hemifield slide diplopia from altitudinal visual field defects. J Neuroophthalmol 1996;16:107–109.

    PubMed  CAS  Google Scholar 

  102. Chamlin M, Davidoff LM, Feiring EH. Ophthalmologic changes produced by pituitary tumors. Am J Ophthalmol 1955;40: 353–368.

    PubMed  CAS  Google Scholar 

  103. Slamovits TL, Burde R. Neuro-ophthalmology, Mosby, St. Louis, 1994, p. 4.3.

    Google Scholar 

  104. Wertenbaker C, Gutman I. Unusual visual symptoms. Sury Ophthalmol 1985;29:297–299.

    CAS  Google Scholar 

  105. Randall RV, Laws E, Jr, Abboud CF, Ebersold MJ, Kao PC, Scheithauer BW. Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients. Mayo Clin Proc 1983;58:108–121.

    PubMed  CAS  Google Scholar 

  106. Neetens A, Selosse P. Oculomotor anomalies in sellar and parasellar pathology. Ophthalmologica 1977;175:80–104.

    PubMed  CAS  Google Scholar 

  107. Drachman DA. See-saw nystagmus. J Neurol Neurosurg Psychiatry 1966;29:356–361.

    PubMed  CAS  Google Scholar 

  108. Dell’Osso LF, Daroff RB. Two additional scenarios for see-saw nystagmus: achiasma and hemichiasma. J Neuroophthalmol 1998; 18:112–113.

    PubMed  Google Scholar 

  109. Apkarian P. Chiasmal crossing defects in disorders of binocular vision. Eye 1996;10:222–232.

    PubMed  Google Scholar 

  110. Leitch RJ, Thompson D, Harris CM, Chong K, Russell-Eggitt I, Kriss A. Achiasma in a case of midline craniofacial cleft with see-saw nystagmus. Br J Ophthalmol 1996;80:1023–1027.

    PubMed  CAS  Google Scholar 

  111. May EF, Truxal AR. Loss of vision alone may result in seesaw nystagmus. J Neuroophthalmol 1997;17:84–85.

    PubMed  CAS  Google Scholar 

  112. Ram Z, Findler G, Gutman I, Tadmor R, Sahar A. Visual hallucinations associated with pituitary adenoma. Neurosurgery 1987;20: 292–296.

    PubMed  CAS  Google Scholar 

  113. Dawson DJ, Enoch BA, Shepherd DI. Formed visual hallucinations with pituitary adenomas. Br Med J 1984;289:414.

    CAS  Google Scholar 

  114. Cogan DG. Visual hallucinations as release phenomena. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1973;188:139–150.

    PubMed  CAS  Google Scholar 

  115. Ruben S, Elston J, Hayward R. Pituitary adenoma presenting as the Foster-Kennedy syndrome. Br J Ophthalmol 1992;76:117–119.

    PubMed  CAS  Google Scholar 

  116. Repka MX, Miller NR, Miller M. Visual outcome after surgical removal of craniopharyngiomas. Ophthalmology 1989;96: 195–199.

    PubMed  CAS  Google Scholar 

  117. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 1999;90:237–250.

    PubMed  CAS  Google Scholar 

  118. Baskin DS, Wilson CB. Surgical management of craniopharyngiomas: A review of 74 cases. J Neurosurg 1986;65:22–27.

    PubMed  CAS  Google Scholar 

  119. Crotty TB, Scheithauer BW, Young WF, Davis DH, Shaw EG, Miller GM, Burger PC. Papillary craniopharyngioma: a clinico-pathological study of 48 cases. J Neurosurg 1995;83:206–214.

    PubMed  CAS  Google Scholar 

  120. Cherninkova S, Tzekov H, Karakostov V. Comparative ophthalmologic studies on children and adults with craniopharyngiomas. Ophthalmologica 1990;201:201–205.

    PubMed  CAS  Google Scholar 

  121. Gokalp HZ, Arasil E, Kanpolat Y, Ralim T. Meningiomas of the tuberculum sella. Neurosurg Rev 1993;16:111–114.

    PubMed  CAS  Google Scholar 

  122. Kinjo T, Al-Mefty O, Ciric I. Diaphragma sellae meningiomas. Neurosurgery 1995;36:1082–1092.

    PubMed  CAS  Google Scholar 

  123. Ross DA, Norman D, Wilson CB. Radiologic characteristics and results of surgical management of Rathke’s cysts in 43 patients. Neurosurgery 1992;30:173–178.

    PubMed  CAS  Google Scholar 

  124. Rao GP, Blyth CPJ, Jeffreys RV. Ophthalmic manifestations of Rathke’s cleft cysts. Am J Ophthalmol 1995;119:86–91.

    PubMed  CAS  Google Scholar 

  125. Kleinschmidt-DeMasters BK, Lillehei KO, Stears JC. The pathologic, surgical, and MR spectrum of Rathke cleft cysts. Surg Neurol 1995;44:19–27.

    PubMed  CAS  Google Scholar 

  126. Voelker JL, Campbell RL, Muller J. Clinical, radiographic, and pathological features of symptomatic Rathke’s cleft cysts. J Neurosurg 1991;74:535–544.

    PubMed  CAS  Google Scholar 

  127. El-Mandy W, Powell M. Transsphenoidal management of 28 symptomatic Rathke’s cleft cysts, with special reference to visual and hormonal recovery. Neurosurgery 1998;42:7–17.

    Google Scholar 

  128. Hornig GW, Zervas NT. Slit defect of the diaphragma sellae with valve effect: observation of a “slit valve”. Neurosurgery 1992;30: 265–267.

    PubMed  CAS  Google Scholar 

  129. Meyer FB, Carpenter SM, Laws ER, Jr. Intrasellar arachnoid cysts. Surg Neurol 1987;28:105–110.

    PubMed  CAS  Google Scholar 

  130. Shin JL, Asa SL, Woodhouse LJ, Smyth HS, Ezzat S. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cysts, and ararachnoid cyst. J Clin Endocrinol Metab 1999;84:3972–3982.

    PubMed  CAS  Google Scholar 

  131. Kupersmith MJ, Rosenberg C, Kleinberg D. Visual loss in pregnant women with pituitary adenomas. Ann Int Med 1994;121:473–477.

    PubMed  CAS  Google Scholar 

  132. Coogan PF, Baron JA, Lambe M. Parity and pituitary adenoma risk. J Natl Cancer Inst 1995;87:1410–1411.

    PubMed  CAS  Google Scholar 

  133. Magyar DM, Marshall JR. Pituitary tumors and pregnancy. Am J Obstet Gynecol 1978;132:739–751.

    PubMed  CAS  Google Scholar 

  134. Nelson PB, Robinson AG, Archer DF, Maroon JC. Symptomatic pituitary tumor enlargement after induced pregnancy. J Neurosurg 1978;49:283–287.

    PubMed  CAS  Google Scholar 

  135. Molitch ME. Management of prolactinomas during pregnancy. J Reprod Med 1999;12(suppl):1121–1126.

    Google Scholar 

  136. Divers W, Jr, Yen SSC. Prolactin-producing microadenomas in pregnancy. Obstet Gynecol 1983;62:425–429.

    PubMed  Google Scholar 

  137. Gemzell C, Wang CF. Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 1979;31:363–372.

    PubMed  CAS  Google Scholar 

  138. Molitch ME. Pregnancy and the hyperprolactinemic woman. N Engl J Med 1985;312:1364–1370.

    PubMed  CAS  Google Scholar 

  139. Melmed S, Braunstein GD, Chang RJ, Becker DP. Pituitary tumors secreting growth hormone and prolactin. Ann Intern Med 1986;105: 238–253.

    PubMed  CAS  Google Scholar 

  140. Van Dalen JTW, Greve EL. Rapid deterioration of visual fields during bromocriptine-induced pregnancy in a patient with a pituitary adenoma. Br J Ophthalmol 1977;61:729–733.

    PubMed  Google Scholar 

  141. Rolih CA, Ober KP. Pituitary apoplexy. Endocrinol Metab Clin North Am 1993;22:291–302.

    PubMed  CAS  Google Scholar 

  142. Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg 1981;55:187–193.

    PubMed  CAS  Google Scholar 

  143. Bonicki W, Kasperlik-Zaluska A, Koszewski W, Zgliczyńíski W, Wislawski J. Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir (Wien) 1993:120:118–122.

    CAS  Google Scholar 

  144. Wright RL, Ojemann R, Drew JH. Haemorrhage into pituitary adenomata; report of 2 cases with spontaneous recovery. Arch Neurol 1965.12:326–330.

    PubMed  CAS  Google Scholar 

  145. Schatz NJ, Job OM, Glaser JS. Spontaneous resolution of pituitary adenoma after apoplexy. J Neuroophthalmol 2000;20:42–44.

    PubMed  CAS  Google Scholar 

  146. Reid RL, Quigley ME, S.S.C. Yen. Pituitary apoplexy: A review. Arch Neurol 1985;42:712–719.

    PubMed  CAS  Google Scholar 

  147. Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and out-come in 21 patients. Neurosurgery 1990;26:980–986.

    PubMed  CAS  Google Scholar 

  148. Bills DC, Meyer RB, Laws ER, Jr, Davis DH, Ebersold MJ, Scheithauer BW, Ilstrup DM, Abboud CF. A retrospective analysis of pituitary apoplexy. Neurosurgery 1993;33:602–609.

    PubMed  CAS  Google Scholar 

  149. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JAH. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol 1999;51:181–188.

    CAS  Google Scholar 

  150. Markowitz S, Sherman L, Kolodny HD, Baruh S. Acute pituitary vascular accident (pituitary apoplexy). Med Clin North Am 1981;65:105–116.

    PubMed  CAS  Google Scholar 

  151. Thompson D, Powell M, Foster O. Atypical presentation of vascular events in pituitary tumours: “non-apoplectic” pituitary apoplexy. J Neurol Neurosurg Psychiatry 1994;57:1441–1442.

    PubMed  CAS  Google Scholar 

  152. Lohmann CP, Kohler M, Ullrich OW. Incomplete bitemporal hemianopia without headache: an unusual case of pituitary apoplexy. Eye 2000;14:116–117.

    PubMed  Google Scholar 

  153. Rossitch E, Carrazana EJ, Black PM. Isolated oculomotor nerve palsy following apoplexy of a pituitary adenoma. J Neurosurg Sci 1992;36:103–105.

    PubMed  Google Scholar 

  154. McDermott MW, Griesdale DE, Berry K, Wilkins E. Lymphocytic adenohypophysitis. Can J Neurol Sci 1988;15:38–43.

    PubMed  CAS  Google Scholar 

  155. Cosman F, Post KD, Holub DA, Wardlaw SL. Lymphocytic hypophysitis. Report of 3 new cases and review of the literature. Medicine 1989;68:240–256.

    PubMed  CAS  Google Scholar 

  156. Thodou E, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S. Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 1995;80:2302–2311.

    PubMed  CAS  Google Scholar 

  157. Stelmach M, O’Day J. Rapid change in visual fields associated with suprasellar lymphocytic hypophysitis. J Clin Neuroophthalmol 1991;11:19–24.

    PubMed  CAS  Google Scholar 

  158. Levine SN, Benzel EC, Fowler MR, Shroyer JV, Mirfakhraee M. Lymphocytic adenohypophysitis: clinical, radiological, and magnetic resonance imaging characterization. Neurosurgery 1988;22: 937–941.

    PubMed  CAS  Google Scholar 

  159. Kerrison JB, Lee AG, Weinstein JM. Acute loss of vision during pregnancy due to a suprasellar mass. Sury Ophthalmol 1997;41: 402–408.

    CAS  Google Scholar 

  160. Katano H, Umemura A, Kamiya K, Kanai H, Yamada K. Visual disturbance by lymphocytic hypophysitis in a non-pregnant woman with systemic lupus erythematosus. Lupus 1998;7:554–556.

    PubMed  CAS  Google Scholar 

  161. Farah JO, Rossi M, Foy PM, MacFarlane IA. Cystic lymphocytic hypophysitis, visual field defects and hypopituitarism. Int J Clin Pract 1999;53:643–644.

    PubMed  CAS  Google Scholar 

  162. Jain KC, Varma A, Mahapatra AK. Pituitary abscess: a series of six cases. Br J Neurosurg 1997;11:139–143.

    PubMed  CAS  Google Scholar 

  163. Domingue JN, Wilson CB. Pituitary abscesses. Report of seven cases and review of the literature. J Neurosurg 1977;46:601–608.

    PubMed  CAS  Google Scholar 

  164. Henegar MM, Koby MB, Silbergeld DL, Rich KM, Moran CJ. Intrasellar abscess following transsphenoidal surgery. Surg Neurol 1996;45:183–188.

    PubMed  CAS  Google Scholar 

  165. Buckman MT, Husain M, Carlow TJ, Peake GT. Primary empty sella syndrome with visual field defects. Am J Med 1976;61: 124–128.

    PubMed  CAS  Google Scholar 

  166. Gallardo E, Schachter D, Caceres E, Becker P, Colin E, Martinez C, Henriques C. The empty sella: results of treatment in 76 successive cases and high frequency of endocrine and neurological disturbances. Clin Endocrinol 1992;37:529–533.

    CAS  Google Scholar 

  167. Bjerre P. The empty sella: a reappraisal of etiology and pathogenesis. Acta Neurol Scand Suppl 1990;130:1–25.

    PubMed  CAS  Google Scholar 

  168. Bjerre P, Gyldensted C, Riishede J, Lindholm J. The empty sella and pituitary adenomas. A theory on the causal relationship. Acta Neurol Scand 1982;66:82–92.

    PubMed  CAS  Google Scholar 

  169. Mortara R, Norrell H. Consequences of a deficient sellar diaphragm. J Neurosurg 1970;32:565–573.

    PubMed  CAS  Google Scholar 

  170. Kirkali P, Kansu T, Erzen C, Cial A. A radiological insight into primary empty sella syndrome with visual dysfunction. Neuro-ophthalmology 1989;9:259–265.

    Google Scholar 

  171. Robinson DB, Michaels RD. Empty sella resulting from the spontaneous resolution of a pituitary macroadenoma. Arch Int Med 1992;152:1920–1923.

    CAS  Google Scholar 

  172. Domingue JN, Wing SD, Wilson CB. Coexisting pituitary adenomas and partially empty sellas. J Neurosurg 1978;48:23–28.

    PubMed  CAS  Google Scholar 

  173. Burrow GN, Wortzman G, Rewcastle NB. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304:156–158.

    PubMed  CAS  Google Scholar 

  174. McCormick WF, Halmi NS. Absence of chromophobe adenomas from a large series of pituitary tumors. Arch Pathol 1971;92: 231–238.

    PubMed  CAS  Google Scholar 

  175. Auer RN, Alakija P, Sutherland GR. Asymptomatic large pituitary adenomas discovered at autopsy. Surg Neurol 1996;46:28–31.

    PubMed  CAS  Google Scholar 

  176. Garcia MM, Kapcala LP. Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy. J Endocrinol Invest 1995:18:450–455.

    PubMed  CAS  Google Scholar 

  177. Molitch ME, Elton RL, Blackwell RE, Caldwell R, Chang RJ, Jaffe R, Joplin G, Robbins RJ, Tyson J, Thorner MO. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab 1985; 60:698–705.

    PubMed  CAS  Google Scholar 

  178. Moster ML, Savino PJ, Schatz NJ, Snyder PJ, Sergott RC, Bosley TM. Visual function in prolactinoma patients treated with bromocriptine. Ophthalmology 1985;92:1332–1341.

    PubMed  CAS  Google Scholar 

  179. Lesser RL, Zheutlin JD, Boghen D, Odel JG, Robbins RJ. Visual function improvement in patients with macroprolactinomas treated with bromocriptine. Am J Ophthalmol 1990;109:535–543.

    PubMed  CAS  Google Scholar 

  180. Lundin P, Bergstrom K, Nyman R, Lundberg PO, Muhr C. Macroprolactinomas: serial MR imaging in long-term bromocriptine therapy. Am J Neuroradiol 1992;13:1279–1291.

    PubMed  CAS  Google Scholar 

  181. Ciccarelli E, Grottoli S, Miola C, Avataneo T, Lancranjan I, Camanni F. Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemia. Clin Endocrinol 1994;40:193–198.

    CAS  Google Scholar 

  182. Ciccarelli E, Miola C, Grottoli S, Avataneo T, Lancranjan I, Camanni F. Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine. J Clin Endocrinol Metab 1993;76:484–488.

    PubMed  CAS  Google Scholar 

  183. Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 1999;84:2518–2522.

    PubMed  CAS  Google Scholar 

  184. Couldwell WT, Weiss MH. Visual loss associated with bromocriptine. Lancet 1992;340:1410–1411.

    PubMed  CAS  Google Scholar 

  185. Taxel P, Waitzman DM, Harrington JF, Fagan RH, Rothfield NF, Chen HH, Malchoff CD. Chiasmal herniation as a complication of bromocriptine therapy. J Neuroophthamol 1996;16:252–257.

    CAS  Google Scholar 

  186. Mori H, Maeda T, Saitoh Y, Onishi T. Changes in prolactinomas and somatotropinomas in humans treated with bromocriptine. Pathol Res Pract 1988;183:580–583.

    PubMed  CAS  Google Scholar 

  187. Perrin G, Treluyer C, Trouillas J, Sassolas G, Goutelle A. Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas. Pathol Res Pract 1991;187:587–592.

    PubMed  CAS  Google Scholar 

  188. Clark J, Wheatley T, Edwards OM. Rapid enlargement of non-functioning pituitary tumor following withdrawal of bromocriptine. J Neurol Neurosurg Psychiatry 1985;48:287.

    PubMed  CAS  Google Scholar 

  189. Thorner MO, Perryman RL, Rogol AD, Conway BP, Macleod RM, Login IS. Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 1981;53:480–483.

    PubMed  CAS  Google Scholar 

  190. Jaffe CA, Barkan AL. Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am 1992;21:13–35.

    Google Scholar 

  191. Vance ML, Evans WS, Thorner MO. Bromocriptine. Ann Int Medicine 1984;100:78–91.

    CAS  Google Scholar 

  192. Wass JAH, Thorner MO, Morris DV, Rees ZH, Mason AS, Jones AE, Besser GM. Long-term treatment of acromegaly with bromocriptine. Br Med J 1977;1:875–878.

    PubMed  CAS  Google Scholar 

  193. Melmed S. Acromegaly. In: Melmed S, ed. The Pituitary. Blackwell Science, Inc., Cambridge, MA, 1995, pp. 413–442.

    Google Scholar 

  194. Thorner MO, Besser GM. Successful treatment of acromegaly with bromocriptine. Postgrad Med J 1976;52 suppl 1:71–74.

    PubMed  Google Scholar 

  195. Barnard LB, Grantham WG, Lamberton P, O’Dorisio TM, Jackson IMD. Treatment of resistant acromegaly with a long-acting somatostatin analogue (SMS 201–995). Ann Int Med 1986;105:856–61.

    PubMed  CAS  Google Scholar 

  196. Jackson IMD, Barnard LB, Lamerton P. Role of long-acting somatostatin analogue (SMS 201–995) in the treatment of acromegaly. Am J Med 1986;81(suppl 6B):94–101.

    PubMed  CAS  Google Scholar 

  197. Cobb W, Jackson IMD. Short-term recovery of visual field loss in acromegaly during treatment with a long-acting somatostatin analogue. Am J Med 1989;86:496–497.

    PubMed  CAS  Google Scholar 

  198. Warnet A, Harris AG, Renard E, Martin D, James-Deidier A, Chaumet-Riffaud P. A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. Neurosurgery 1997;41: 786–795.

    PubMed  CAS  Google Scholar 

  199. Kayan A, Earl CJ. Compressive lesions of the optic nerves and chiasm. Brain 1975;98:13–28.

    PubMed  CAS  Google Scholar 

  200. Ciric I, Mikhael M, Stafford T, Lawson L, Garces R. Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 1983;59:395–401.

    PubMed  CAS  Google Scholar 

  201. Goldman JA, Hedges III T, Shucart W, Molitch ME. Delayed chiasmal decompression after transsphenoidal operation for a pituitary adenoma. Neurosurgery 1985;17:962–964.

    PubMed  CAS  Google Scholar 

  202. Teng MM, Huang CI, Chang T. The pituitary mass after transsphenoidal hypophysectomy. Am J Neuroradiol 1988; 9:23–26.

    PubMed  CAS  Google Scholar 

  203. Colao A, Cerbone G, Cappabianca P, Ferone D, Alfieri A, Di Salle F, Faggiano A, Merola B, de Divitiis E, Lombardi G. Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. J Endocrinol Invest 1998;21: 284–290.

    PubMed  CAS  Google Scholar 

  204. Nakane T, Kuwayama A, Watanabe M, Kageyama N. Transsphenoidal approach to pituitary adenomas with suprasellar extension. Surg Neurol 1981;16:225–229.

    Google Scholar 

  205. Hajda M, Pásztor E. Significance of the appearance of the optic disc for predicting visual function following removal of pituitary adenomas. Neurolog Med Chir (Tokyo) 1983;23:561–565.

    CAS  Google Scholar 

  206. Wilson P, Falconer MA. Patterns of visual failure with pituitary tumours. Br J Ophthalmol 1968;52:94–110.

    PubMed  CAS  Google Scholar 

  207. El-Azouzi M, Black PM, Candia G, Zervas NT, Panagopoulos KP. Transsphenoidal surgery for visual loss in patients with pituitary adenomas. Neurol Res 1990;12:23–25.

    PubMed  CAS  Google Scholar 

  208. Black PM, Zervas NT, Candia GL. Incidence and management of complications of transsphenoidal operation for pituitary adenomas. Neurosurgery 1987;20:920–924.

    PubMed  CAS  Google Scholar 

  209. Laws E, Jr, Kern EB. Complications of transphenoidal surgery. Clin Neurosurg 1976;23:401–416.

    PubMed  Google Scholar 

  210. Lorenz M, Renella RR. Intraoperative monitoring: visual evoked potentials in surgery of the sellar region. Zentralbl Neurochir 1989;50:12–15.

    PubMed  CAS  Google Scholar 

  211. Wilson WB, Kirsch WM, Neville H, Stears J, Feinsod M, Lehman RAW. Monitoring of visual function during parasellar surgery. Surg Neurol 1976;5:323–329.

    PubMed  CAS  Google Scholar 

  212. Slavin ML, Lam BL, Decker RE, Schatz NJ, Glaser JS, Reynolds MG. Chiasmal compression from fat packing after transsphenoidal resection of intrasellar tumor in two patients. Am J Ophthalmol 1993;115:368–371.

    PubMed  CAS  Google Scholar 

  213. Adams CBT. The management of pituitary tumours and post-operative visual deterioration. Acta Neurochir (Wien) 1988;94:103–116.

    CAS  Google Scholar 

  214. Czech T, Wolfsberger S, Reitner A, Görzer H. Delayed visual deterioration after surgery for pituitary adenoma. Acta Neurochir (Wien) 1999;141:45–51.

    CAS  Google Scholar 

  215. Duff JM, Meyer FB, Ilstrup DM, Laws E, Jr, Schleck CD, Scheithauer BW. Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 2000;46:291–305.

    PubMed  CAS  Google Scholar 

  216. Abrams LS, Repka MX. Visual outcome of craniopharyngioma in children. J Pediatr Ophthalmol Strabismus 1997;34:223–228.

    PubMed  CAS  Google Scholar 

  217. Konig A, Ludecke DK, Herrman HD. Transnasal surgery in the treatment of craniopharyngiomas. Acta Neurochir (Wien) 1986;83:1–7.

    CAS  Google Scholar 

  218. Pierre-Kahn A, Sainte-Rose C, Renier D. Surgical approach to children with craniopharyngiomas and severely impaired vision: special considerations. Pediatr Neurosurg 1994;21 Suppl 1:50–56.

    PubMed  Google Scholar 

  219. Mashima Y, Oguchi Y. Visual evoked potential in the management of pituitary tumor during pregnancy. Doc Ophthalmol 1987;65:57–64.

    PubMed  CAS  Google Scholar 

  220. Griffith RW, Trukalj I, Braun P. Outcome of pregnancy in mothers given bromocriptine. Br. J. Clin. Pharmacol 1978;5:227.

    PubMed  CAS  Google Scholar 

  221. Vidal E, Cevallos R, Vidal J, Rayon R, Moreau JJ, Rogues AM, Loustaud V, Liozon F. Twelve cases of pituitary apoplexy. Arch Intern Med 1992;152:1893–1899.

    PubMed  CAS  Google Scholar 

  222. Lloyd MH, Belchetz PE. The clinical features and management of pituitary apoplexy. Postgrad Med J 1977;53:82–85.

    PubMed  Google Scholar 

  223. Maccagnan P, Macedo CLD, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 1995;80:2190–2197.

    PubMed  CAS  Google Scholar 

  224. Hamlyn PJ, Baer R, Afshar F. Transsphenoidal chiasmopexy for long standing visual failure in the secondary empty sella syndrome. Br J Neurosurg 1988;2:277–279.

    PubMed  CAS  Google Scholar 

  225. Laws ER, Jr, Vance M. Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 1999;10:327–336.

    PubMed  Google Scholar 

  226. Kondziolka DS, Flickinger JC, Lunsford LD. Radiation Therapy and Radiosurgery of Pituitary Tumors. In: Krisht AF, Tindall GT, eds. Pituitary Disorders. Lippincott Williams & Wilkins, Baltimore, 1999, pp. 407–415.

    Google Scholar 

  227. Hall WA. Stereotactic Radiosurgery in Perspective. In: Cohen AR, Haines SJ, eds. Concepts in Neurosurgery. 7, Williams & Wilkins, Baltimore, 1995, p. 114.

    Google Scholar 

  228. Girkin CA, Comey CH, Lunsford LD, Goodman ML, Kline LB. Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology 1997;104:1634–1643.

    PubMed  CAS  Google Scholar 

  229. Piquemal R, Cottier JP, Arsene S, Lioret E, Rospars C, Herbreteau D, Jan M, Renard JP. Radiation-induced optic neuropathy 4 years after radiation: report of a case followed up with MRI. Neuroradiology 1998;40:439–441.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Stiver, S.I., Sharpe, J.A. (2001). Neuro-Ophthalmologic Evaluation of Pituitary Tumors. In: Thapar, K., Kovacs, K., Scheithauer, B.W., Lloyd, R.V. (eds) Diagnosis and Management of Pituitary Tumors. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-217-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-217-3_10

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9693-2

  • Online ISBN: 978-1-59259-217-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics